抗凝治疗可减少下腔静脉滤器相关亚段非闭塞性血栓负荷
单中心回顾性研究纳入2018年7月至2023年12月放置并回收下腔静脉滤器的患者,分析亚段非闭塞性滤器相关血栓的抗凝治疗及血栓体积变化危险因素。肾上组额外抗凝时间显著长于肾下组,抗凝后多数血栓完全或部分溶解,肾上组结局显著更优。
要点
- 抗凝治疗可减少亚段非闭塞性滤器相关血栓负荷
- 肾上滤器放置与更长抗凝时间可能促进血栓溶解
- 抗凝后多数滤器相关血栓完全或部分溶解
核心结论
- 抗凝治疗可减少亚段非闭塞性滤器相关血栓负荷,更长抗凝时间和肾上滤器放置可能是影响血栓溶解的因素。
研究设计与样本
- 单中心回顾性研究,回顾2018年7月至2023年12月接受下腔静脉滤器放置和回收的患者,纳入亚段非闭塞性滤器相关血栓患者。
- 肾下组32例(男17例,女15例,年龄60.94±13.47岁),肾上组38例(男28例,女10例,年龄54.97±12.48岁)。
主要发现
- 肾上组滤器取出前额外抗凝时间显著长于肾下组(74.47±42.85 vs 51.25±25.99,p<0.05)。
- 额外抗凝后,多数滤器相关血栓完全溶解(肾上组34/38 vs 肾下组20/32)或部分溶解(4/38 vs 9/32),仅肾下组3例进展。
- 肾上组滤器相关血栓结局显著优于肾下组(p<0.05)。
临床怎么用
- 对亚段非闭塞性滤器相关血栓可考虑抗凝治疗以减轻血栓负荷,可能提高滤器回收率。
局限性
- 本研究为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the anticoagulation therapy of subsegmental nonocclusive filter-related thrombus and identify the risk factors affecting the change in thrombus volume. METHODS: A single-center retrospective study was performed to review patients who received inferior vena cava filter (IVCF) placements and retrievals from July 2018 to December 2023. Patients with subsegmental nonocclusive filter-related thrombus were included in this study, and clinical data, such as demographics, baseline medical history, types of IVCFs, locations of IVCFs, endovascular management, duration of anticoagulation, and outcomes were collected. RESULTS: Based on IVCF location, 32 patients, including 17 men and 15 women (age: 60.94±13.47) were enrolled into infrarenal IVCF group (infra-group), 38 patients, including 28 men and 10 women (age 54.97±12.48) were enrolled into suprarenal IVCF group (supra-group). Demographics, baseline medical history, lower extremity deep vein thrombosis (DVT) characteristics, initial IVCF placement indications, IVCF types, endovascular therapy choice, and the reasons of additional anticoagulation were found no significant difference between the 2 groups (p>0.05). Additional anticoagulation time before IVCF removal in supra-group was significantly longer than infra-group (74.47±42.85 vs 51.25±25.99 p<0.05). After additional anticoagulation, most filter-related thrombus was resolved completely (34/38 vs 20/32) or partially (4/38 vs 9/32), and only 3 patients in infra-group suffered progressed filter-related thrombus. Supra-group had a significantly better outcome of filter-related thrombus than the infra-group (p<0.05). CONCLUSION: Anticoagulation therapy could reduce subsegmental nonocclusive filter-related thrombus burden. Longer anticoagulation period and suprarenal IVCF placement may be the factors influencing the thrombus resolve.Clinical ImpactThe present study found out anticoagulation therapy could reduce subsegmental nonocclusive filter-related thrombus burden, which may provide a better option for filter-related thrombus and improve the retrieval rate of inferior vena cava filters.
引用
- Cao P, Luo X, Li Y, et al. Anticoagulation Therapy May Reduce Subsegmental Nonocclusive Inferior Vena Cava Filter-Related Thrombus Burden: A Retrospective Study in a Single-Center Institution. J Endovasc Ther. 2025. PMID: 41165317. doi:10.1177/15266028251384946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。